9-130579741-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_003934.2(FUBP3):c.61G>A(p.Asp21Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000159 in 1,129,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003934.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FUBP3 | NM_003934.2 | c.61G>A | p.Asp21Asn | missense_variant | Exon 1 of 19 | ENST00000319725.10 | NP_003925.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FUBP3 | ENST00000319725.10 | c.61G>A | p.Asp21Asn | missense_variant | Exon 1 of 19 | 1 | NM_003934.2 | ENSP00000318177.9 | ||
FUBP3 | ENST00000467100.1 | n.777G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
FUBP3 | ENST00000650723.1 | n.61G>A | non_coding_transcript_exon_variant | Exon 1 of 21 | ENSP00000499109.1 | |||||
FUBP3 | ENST00000699747.1 | n.61G>A | non_coding_transcript_exon_variant | Exon 1 of 19 | ENSP00000514557.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000154 AC: 1AN: 64940Hom.: 0 AF XY: 0.0000274 AC XY: 1AN XY: 36528
GnomAD4 exome AF: 0.0000159 AC: 18AN: 1129066Hom.: 0 Cov.: 30 AF XY: 0.0000112 AC XY: 6AN XY: 537868
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.61G>A (p.D21N) alteration is located in exon 1 (coding exon 1) of the FUBP3 gene. This alteration results from a G to A substitution at nucleotide position 61, causing the aspartic acid (D) at amino acid position 21 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at